Today: 16 March 2026
Subscribe
Browse Category

TSX:9434 3 February 2026

Intel stock jumps in premarket after SoftBank AI-memory tie-up, new Xeon launch

Intel stock jumps in premarket after SoftBank AI-memory tie-up, new Xeon launch

Intel shares rose 2.7% to $50.14 in premarket trading Tuesday after SoftBank’s SAIMEMORY unit announced a partnership with Intel to develop advanced memory for AI data centers. The deal was unveiled as Intel stock extended Monday’s 5% rally, outpacing broader markets. Intel also launched new Xeon 600 workstation chips and disclosed a planned insider share sale. Traders are watching for major tech earnings this week.
3 February 2026
···

Stock Market Today

  • JNJ's Bladder Cancer Therapy Erda-iDRS Hits Primary Safety Endpoint in Early-Stage Trial
    March 16, 2026, 2:59 PM EDT. Johnson & Johnson's (JNJ) investigational bladder cancer treatment, Erda-iDRS, met its primary safety endpoint in a Phase I study targeting non-muscle-invasive bladder cancer (NMIBC) with FGFR gene alterations, found in up to 70% of intermediate-risk and 40% of high-risk patients. The localized drug-delivery system releases erdafitinib directly into the bladder, limiting systemic side effects. Results showed an 89% complete response (CR) rate in intermediate-risk patients, with median CR duration around 18 months. High-risk patients saw median recurrence-free survival of 20 months and 83% survival at 12 months. The therapy was generally well-tolerated with mild to moderate adverse effects and no dose-limiting toxicities. Shares of JNJ rose 36.3% over six months, outperforming the 17.2% industry gain, as the company prepares for further development steps.
Go toTop